Quick Navigation

Rhamnus nakaharai

Rhamnus Nakaharai is a herb that has been used as folk medicine in Taiwan for intestinal distress (mostly constipation) and asthma, it is a good source of Quercetin glycosides but not much research exists on the herb per se.

Our evidence-based analysis on rhamnus nakaharai features 5 unique references to scientific papers.

Research analysis led by .
Reviewed by
Examine.com Team
Last Updated:

Easily stay on top of the latest research

Become an Examine Personalized member to get access to all of the latest nutrition research:

  • Unlock information on 400+ supplements and 600+ health topics.
  • Get a monthly report summarizing studies in the health categories that matter specifically to you.

Try FREE for 7 days

Research Breakdown on Rhamnus nakaharai


1Sources and composition

1.1Sources and History

Rhamnus Nakaharia (from the family Rhamnaceae) is a folk medicine originating in Taiwan that has been used to treat constipation, inflammation, malignant tumors, and asthma.[1]

1.2Composition

Rhamnus Nakaharai (RN) is a Taiwanese herbal medicine that contains:

  • The napthalenic compound 6-methoxysorigenin and various glycosides and acylates of the parent compound, such as alpha-sorinin[1] although 6-methoxyorigenin appears to be isolated from the wood component of the herb[1]

  • Isotorachyrsone and derivatives.[2][3]

  • Quercetin glycosides, specifically 3-O-Methylquercetin.[2][4]

2Interactions with Oxidation

The compound 6-methoxyorigenin appears to have anti-oxidative effects in vitro,[1] as well as the related compound Isotorachrysone, which share structural similarities.[3] 6-methoxygenin outperformed Trolox (a research standard) on Metal-chelating and protecting from lipid peroxidation, and was slightly outperformed on a DPPH test.[1] The IC50 of the metal chelating ability of 6-methoxyorigenin (615.90+/-5.79) was lesser than that of EDTA (127.92+/-6.27).[1]

3Inflammation and Immunology

3.1Mechanisms

3-O-Methylquercetin has been found to suppress the inflammatory (Nitric Oxide mediated) response from LPS (research pro-inflammatory agent) in macrophages in vitro.[4] 3-O-Methylquercetin was found to inhibit Nitric Oxide release, protein expression of iNOS (induced by inflammation) and mRNA translation of iNOS with IC50 values of 4.23uM, 4.36uM, and 6.53uM respectively.[4]

4Intestinal Interactions

4.1Mechanisms

3-O-Methylquercetin appears to be a selective PDE3 inhibitor with an IC50 of 1.6mM via competitive inhibition.[5]